Ghrelin’s ability to modulate cytokine profiles in inflammatory contexts positions it as a promising candidate for developing novel therapeutic strategies for inflammatory diseases of the endometrium, such as endometriosis, which is characterized by cytokine imbalances. This evidence concerns the gene GHRL and endometriosis.